Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Preferred Shares (2016 - 2019)

Historic Preferred Shares for SRx Health Solutions (SRXH) over the last 9 years, with Q3 2019 value amounting to $13.0 million.

  • SRx Health Solutions' Preferred Shares changed N/A to $13.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was $13.0 million, marking a year-over-year change of. This contributed to the annual value of $2000.0 for FY2018, which is N/A changed from last year.
  • As of Q3 2019, SRx Health Solutions' Preferred Shares stood at $13.0 million.
  • SRx Health Solutions' Preferred Shares' 5-year high stood at $13.0 million during Q2 2019, with a 5-year trough of $1.0 in Q1 2015.
  • For the 5-year period, SRx Health Solutions' Preferred Shares averaged around $1.4 million, with its median value being $1.0 (2015).
  • Per our database at Business Quant, SRx Health Solutions' Preferred Shares changed by 0.0% in 2015 and then soared by 28450000.0% in 2018.
  • SRx Health Solutions' Preferred Shares (Quarter) stood at $1.0 in 2015, then changed by 0.0% to $1.0 in 2016, then changed by 0.0% to $1.0 in 2017, then skyrocketed by 284500.0% to $2846.0 in 2018, then soared by 456927.41% to $13.0 million in 2019.
  • Its last three reported values are $13.0 million in Q3 2019, $13.0 million for Q2 2019, and $2846.0 during Q4 2018.